News about Global Pharma

FDA Approves RYBREVANT Plus Chemotherapy for NSCLC with EGFR Exon 20 Insertion Mutations

This approval, following a priority review, builds upon the accelerated approval of RYBREVANT® in May 2021, based on the Phase 3 PAPILLON study results.

Global Pharma | 02/03/2024 | By Manvi |  587

Dr. Rahul Rathod Named Global Principal Investigator for Mezzion Pharmaceuticals' FUEL-2 Trial

Dr. Rathod, a distinguished pediatric cardiology specialist with over two decades of expertise at Boston Children's Hospital, brings extensive experience to this crucial role.

Global Pharma | 02/03/2024 | By Manvi |  923

Ginkgo Bioworks Acquires Reverie Labs to Strengthen AI-Driven Drug Discovery

This strategic move aims to enhance Ginkgo's capabilities in AI-driven drug discovery and advance its efforts in developing next-generation biological foundation models.

Global Pharma | 01/03/2024 | By Manvi |  962

AbbVie and OSE Immunotherapeutics Forge Partnership to Advance OSE-230 Monoclonal Antibody

OSE-230 represents a pioneering approach as a first-in-class monoclonal antibody designed to activate ChemR23, a G-Protein Coupled Receptor (GPCR) target.

Global Pharma | 01/03/2024 | By Manvi |  357

Gericke Celebrates 130 Years of Bulk Handling Solutions

For over a century, the Swiss family-owned company has been a leader in the manufacture of systems and machines for processing bulk solids. What once began in a modest location in Zurich has developed into a global group of companies with 350 employees.

Global Pharma | 01/03/2024 | By Manvi |  373

API Launches Website 'Cough Xpert' at its 79th Annual Conference 'APICON' in New Delhi

The user-friendly website, Cough Xpert is designed to assist Healthcare Professionals in determining cough symptom differentials based on various parameters such as the type of cough, mucus, triggering factors, and accompanying symptoms.

Global Pharma | 29/02/2024 | By Manvi |  879

TechInvention Lifecare Announce Ground Breaking of its Global Collaborative Centre for Medical Countermeasures

TechInvention Lifecare Pvt. Ltd. is proud to announce the ground breaking of its Global Collaborative Centre for Medical Countermeasures (GCMC) with an investment of approx. USD 15 million. The centre is strategically located close to the upcoming international a

Global Pharma | 29/02/2024 | By Manvi |  917

Telix Pharmaceuticals Acquires IsoTherapeutics Group

One of the key benefits of this acquisition is the enhancement of Telix's manufacturing capabilities, particularly in the United States.

Global Pharma | 29/02/2024 | By Manvi |  854

RRD International Launches New Brand RRD Biopharma Development

RRD International announced the launch of its new brand, RRD Biopharma Development, representing its unique offering of strategy-driven product development services for biopharmaceutical companies and investors .

Global Pharma | 28/02/2024 | By Manvi |  693

PENTAX Medical Introduces Enhanced i20c Video Endoscope Series to Advance Patient Care

The newly approved models include the PENTAX Medical Video Colonoscope EC34-i20c, PENTAX Medical Video Upper GI Scope EG27-i20c, and the R/L Knob Adaptor OE-B17.

Global Pharma | 27/02/2024 | By Manvi |  715